Journals / MN Kardiyoloji / 2022 / Cilt: 29 - Sayı: 2

The Usefulness of CHA2DS2-VASc Score to Predict Chest Computed Tomography Involvement in Asymptomatic COVID-19 Patients

CHA2DS2-VASc Skorunun Asemptomatik COVID-19 Hastalarında Bilgisayarlı Tomografi Tutulum Şiddetini Öngörmede Yararlılığı

Pages
56–65
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: Hypertension and vascular disease are linked to greater chest computed tomography severity score (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The central function of computed tomography in the diagnosis and evaluation of illness severity and outcome is to diagnose and assess the severity of disease and outcome.
📊
Key Findings & Data:Material ad Method: By examining the chest computed tomography severity score in detail, 348 reverse transcription polymerase chain reaction positive patients with computed tomography pictures were split into three groups.
💡
Conclusion & Impact:Results: Hypertension and vascular disease are linked to greater chest computed tomography severity score (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The central function of computed tomography in the diagnosis and evaluation of illness severity and outcome is to diagnose and assess the severity of disease and outcome. The goal of this study was to find factors that might help predict the first chest com‐ puted tomography severity score for early hospitalization in asymptomatic or minimally symptomatic individuals. Material ad Method: By examining the chest computed tomography severity score in detail, 348 reverse transcription polymerase chain reaction positive patients with computed tomography pictures were split into three groups. The computed tomography severity scores of 1‐20, 21‐30, and 31‐40, respectively, were used to classify mild, moderate‐severe, and severe involvement. Results: Hypertension and vascular disease are linked to greater chest computed tomography severity score (p

Özet

Amaç: Bilgisayarlı tomografi COVID‐19 hastalık tanısında ve şiddetinin değerlendirilmesinde önemli bir rol oynar. Bu çalışma, asempto‐ matik veya hafif semptomatik hastalarda, erken hastane yatışını sağlayabilmek için, bilgisayarlı tomografi tutulumu şiddet skorunun de‐ ğerlendirilmesine yardımcı olabilecek birkaç parametreyi tanımlamayı amaçlamaktadır. Gereç ve Yöntem: Torakal bilgisayarlı tomografi görüntüsü COVID‐19 endikasyonu dışında alınmış toplam 348 ters transkripsiyon poli‐ meraz zincir reaksiyonu pozitif hasta, bilgisayarlı tomografi tutulum şiddet skorları detaylı olarak değerlendirilerek üç gruba ayrıldı. Bu üç grup, sırasıyla hafif (1‐20), orta‐şiddetli (21‐30) ve şiddetli (31‐40) tutulum olarak gruplandırıldı. Bulgular: Kategorik değişkenlerin analizi; CHA2DS2‐VASc risk skoru arttıkça şiddet skorunun artma eğiliminde olduğunu gösterdi. Hiper ‐ t an siyon ve vasküler hastalığın daha yüksek şiddet skoru ile ilişkili olduğu bulundu (tümü için p

🔖

Cite This Article

KAŞALI, K., GÜRLER, V., GÜNER, A., KETEN, M. F., TONKAZ, G., ÖZKAN, M., KALKAN, S., GÜNDÜZ, S. (2022). The Usefulness of CHA2DS2-VASc Score to Predict Chest Computed Tomography Involvement in Asymptomatic COVID-19 Patients. MN Kardiyoloji, Cilt: 29 - Sayı: 2, 56–65. https://ajindex.com/articles/581452

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Li Y. and Xia L. Coronavirus Disease 2019 (COVID­19): Role of Chest CT in Diagnosis and Management. Am J Roent ge ­ nol. 2020;214(6):1280­6
  2. Colombi D. Bodini FC. Petrini M. et al. Well­aerated Lung on Admitting Chest CT to Predict Adverse Outcome in COVID­19 Pneumonia. Radiology. 2020;296(2):E86­E96
  3. Ran Y. Xiang L. Huan L. et al. Chest CT Severity Score: An Imaging Tool for Assessing Severe COVID­19. Radiol Cardiothorac Imaging. 2020;2(2):e200047. doi.org/10. 1148/ryct.2020200047
  4. Hindricks G. Potpara T. Dagres N. et al. ESC Scientific Document Group; 2020 ESC Guideli nes for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio­Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5): 373­498
  5. Ruocco G. McCullough PA. Tecson KM. et al. Mortality Risk Assessment Using CHA(2)DS(2)­VASc Scores in Patients Hospitalized with Coronavirus Disease 2019 Infection. Am J Cardiol. 2020;137:111­7
  6. Lippi G. Wong J. Henry BM. Hypertension and its severity or mortality in Coronavirus Disease 2019 (COVID­19): a pooled analysis. Polish Arc Intern Med. 2020;130(4):304­9
  7. Huang I. Lim MA. Pranata R. Diabetes mellitus is associated with increased mortality and severity of disease in COVID19 pneumonia. A systematic review, meta­analysis, and meta­regression. Diabetes Metab Syndr. 2020;14(4):395­ 403
  8. Ssentongo P. Ssentongo AE. Heilbrunn ES. Ba DM. Chinchilli VM. Association of cardiovascular disease and 10 other pre­existing comorbidities with COVID­19 mortality: A systematic review and meta­analysis. PLoS One. 2020;15(8):e0238215
  9. Mandeep RM. Sapan SD. SreyRam K. Timothy DH. Amit NP. Cardiovascular disease, drug therapy, and mortality in COVID­19.N Engl J Med. 2020;382:e102
  10. Palaiodimos L. Kokkinidis DG. Li W. et al. Severe obesity, increasing age and male sex are independently associated with worse in­hospital outcomes, and higher in­hospital mortality, in a cohort of patients with COVID­19 in the Bronx, New York. Metabolism. 2020;108:154262
  11. Tao G. Yongzhen F. Ming C. et al. Cardiovascular Implications of Fatal Outcomes of Patients with Coro navi ­ rus Disease 2019 (COVID­19). JAMA Cardiol. 2020;5(7): 811­18. doi:10.1001/jamacardio.2020.1017
  12. Yuwei L. Xuebei D. Jin